Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy Subjects

• Status: Completed
• Trial end date: 2019-01-31
• Target enrollment: 0
• Participant gender: All

Summary

Treatment with colloidal solutions has during long time been a cornerstone within intensive care. Lately there has been a shift from synthetic colloids to natural albumine.

One of these solutions is the hyperoncotic "Albumin 20%". There are however still several aspects of the physiological effects of hyperoncotic albumin, that are not known.

In this study the main object is to study with what rate hyperoncotic albumin should be administered. Rapidly 30 minutes or slower 120 minutes.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Hospital, Linkoeping
• Treatments: Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Healthy, without allergies and with the age 18 years or above

Exclusion Criteria:

• Heart failure

• Signs of kidney injury/failure

• Severe allergies

• Pregnancy